|
|
|
|
ConsulTech GmbH
|
|
ConsulTech GmbH
|
|
ConsulTech is a consulting company founded in 1992. Since then, we have been supporting biotech-nology, pharmaceutical and medical technology companies as well as research institutions with the entire process of setting-up and executing proposals for R&D projects. In projects funded by the European Commission, ConsulTech supports the coordinator by resuming administrative tasks allow-ing coordinators and partners to fully concentrate on the scientific and technical success of the pro-ject. We solve financial and administrative issues, organise meetings, take care of the timely delivery of milestones and reports and much more.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Turkish Cargo maintains its dual-terminal operations seamlessly
Completing the gradual transition process to Istanbul Airport, one of the largest airports of the world, the global air cargo brand Turkish Cargo maintains its dual-terminal operations with full capacity on 7/24 basis without any sales restriction.
More info >> |
|
 |
White Papers |
 |
|
Another Successful Visit Against the Odds
Medical Research Network (MRN) Limited
Our dedicated team of nurses, couriers and project managers deliver, come rain or shine.
Making sure a Clinical Trial visit can go ahead in the home can be a
complex process, and last month bad weather nearly stopped play on an
important Home Trial Support visit. Thanks to the commitment and
dedication from the entire team it went ahead against the odds.
More info >> |
|
 |
Industry Events |
 |
ELRIG Drug Discovery 2019 – Looking Back to the Future
5-6 November 2019, ACC, Liverpool
Now in its 13th year, ELRIG’s flagship conference Drug Discovery 2019 will take place at
ACC in Liverpool.
This year’s focus, ‘A Look Back to the Future’ is planned to include plenary introductions
assessing how we got to where we are now and setting the challenges for discovering the
drugs of the future. These will be followed by cutting edge talks and examples of new
directions in drug discovery.
Our scientific programme will feature over 40 world-class speakers with 6 main session
tracks. In partnership with key academic and charitable groups, we will also run joint
disease and biology-oriented tracks focusing on the basic sciences that underpin
successful drug discovery.
More info >> |
|
|
|
